Your browser is no longer supported. Please, upgrade your browser.
AXGN AxoGen, Inc. monthly Stock Chart
AXGN [NASD]
AxoGen, Inc.
Index- P/E- EPS (ttm)-0.63 Insider Own2.50% Shs Outstand40.09M Perf Week-3.36%
Market Cap593.75M Forward P/E- EPS next Y-0.37 Insider Trans-9.42% Shs Float38.71M Perf Month17.97%
Income-24.80M PEG- EPS next Q-0.13 Inst Own82.00% Short Float2.88% Perf Quarter22.91%
Sales108.00M P/S5.50 EPS this Y-23.10% Inst Trans-1.01% Short Ratio4.02 Perf Half Y47.94%
Book/sh3.04 P/B4.73 EPS next Y14.00% ROA-15.00% Target Price18.00 Perf Year-17.19%
Cash/sh2.40 P/C5.99 EPS next 5Y- ROE-19.90% 52W Range7.16 - 18.84 Perf YTD-19.62%
Dividend- P/FCF- EPS past 5Y5.80% ROI-23.80% 52W High-23.67% Beta0.72
Dividend %- Quick Ratio6.80 Sales past 5Y44.70% Gross Margin78.50% 52W Low100.84% ATR0.66
Employees371 Current Ratio7.40 Sales Q/Q16.80% Oper. Margin-23.30% RSI (14)57.42 Volatility3.52% 4.83%
OptionableYes Debt/Eq0.26 EPS Q/Q73.90% Profit Margin-23.00% Rel Volume0.25 Prev Close14.27
ShortableYes LT Debt/Eq0.26 EarningsOct 29 AMC Payout- Avg Volume277.67K Price14.38
Recom1.90 SMA201.35% SMA508.56% SMA20029.04% Volume68,354 Change0.77%
Oct-23-20Initiated Guggenheim Buy $24
Jun-16-20Resumed Cantor Fitzgerald Overweight $16
May-07-20Downgrade Canaccord Genuity Buy → Hold $12
Apr-02-20Downgrade BTIG Research Buy → Neutral
Aug-07-19Downgrade William Blair Outperform → Mkt Perform
Jul-12-19Initiated Canaccord Genuity Buy $32
Mar-02-18Reiterated Lake Street Buy $26 → $38
Jan-05-18Resumed Cantor Fitzgerald Overweight
Nov-30-17Initiated Jefferies Buy $35
Nov-21-17Reiterated Lake Street Buy $22 → $26
Jul-31-17Initiated Leerink Partners Outperform $22
Jun-30-17Initiated Cantor Fitzgerald Overweight $18
Mar-06-17Initiated ROTH Capital Buy $14.50
Nov-22-16Upgrade Lake Street Hold → Buy $9 → $11
Nov-07-16Reiterated Wedbush Outperform $10 → $12
Nov-03-16Downgrade Lake Street Buy → Hold $9
Aug-04-16Reiterated Wedbush Outperform $9 → $10
May-14-14Initiated Dawson James Buy $5
Oct-31-13Reiterated Ladenburg Thalmann Buy $4.50 → $5.75
Nov-06-20 05:38AM  
Nov-04-20 07:00AM  
Oct-30-20 02:31PM  
Oct-29-20 06:55PM  
04:01PM  
02:45PM  
Oct-28-20 10:15AM  
Oct-08-20 07:00AM  
Sep-30-20 04:01PM  
Sep-25-20 07:00AM  
Sep-24-20 07:00AM  
Aug-31-20 07:00AM  
Aug-07-20 09:48AM  
Aug-05-20 07:45PM  
04:01PM  
Jul-29-20 12:33PM  
07:00AM  
Jul-22-20 07:00AM  
Jul-15-20 07:00AM  
Jul-08-20 06:41PM  
Jul-01-20 07:00AM  
Jun-23-20 09:46AM  
Jun-01-20 07:00AM  
May-20-20 07:00AM  
May-07-20 12:00PM  
May-06-20 04:01PM  
Apr-29-20 12:34PM  
Apr-23-20 07:00AM  
Apr-15-20 07:00AM  
Apr-12-20 09:21AM  
Mar-06-20 07:05AM  
Mar-02-20 07:00AM  
Feb-27-20 07:20AM  
Feb-24-20 04:01PM  
Feb-23-20 06:38PM  
Feb-05-20 07:00AM  
Feb-03-20 07:00AM  
05:55AM  
Jan-13-20 07:00AM  
Jan-08-20 07:00AM  
Jan-02-20 04:01PM  
07:00AM  
Dec-19-19 06:47AM  
Dec-18-19 07:00AM  
Dec-13-19 11:03AM  
Dec-04-19 07:00AM  
Nov-22-19 12:19PM  
Nov-21-19 07:00AM  
Nov-11-19 07:00AM  
Nov-09-19 07:02PM  
Nov-06-19 06:35PM  
04:04PM  
Nov-04-19 06:12AM  
Oct-30-19 10:34AM  
Oct-23-19 07:00AM  
Oct-03-19 01:40PM  
Sep-20-19 10:38AM  
Sep-19-19 07:00AM  
Sep-11-19 08:00PM  
Sep-05-19 12:38AM  
Aug-27-19 07:00AM  
Aug-18-19 05:59PM  
Aug-14-19 09:02PM  
01:55PM  
Aug-12-19 10:15AM  
Aug-06-19 08:24PM  
06:55PM  
02:11PM  
Jul-30-19 10:38AM  
Jul-29-19 07:00AM  
Jul-26-19 07:50AM  
07:00AM  
Jul-23-19 07:00AM  
Jul-22-19 06:44PM  
Jul-19-19 12:09PM  
Jun-18-19 02:40PM  
Jun-14-19 04:38PM  
Jun-06-19 03:31AM  
May-23-19 07:00AM  
May-09-19 12:23AM  
May-08-19 05:45PM  
04:41PM  
04:01PM  
May-04-19 09:39PM  
May-02-19 07:00AM  
May-01-19 10:32AM  
Apr-22-19 07:01AM  
07:00AM  
Apr-16-19 03:28PM  
Mar-22-19 06:26PM  
Mar-20-19 11:54AM  
Mar-11-19 11:19AM  
10:44AM  
Mar-10-19 10:50PM  
06:00PM  
10:05AM  
Mar-08-19 10:50PM  
09:30PM  
06:07PM  
01:13PM  
AxoGen, Inc., together with its subsidiaries, provides surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and Avive Soft Tissue Membrane, a minimally processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues in the surgical bed. In addition, the company offers AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. It provides its products to hospitals, surgery centers, and military hospitals plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons in the United States, Canada, the United Kingdom and other European countries, South Korea, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Donovan Michael PatrickVP OperationsNov 09Sale15.0017,617264,25526,029Nov 12 10:14 AM
Zaderej Karen L.CEONov 09Sale14.5314,000203,420644,869Nov 10 09:56 AM
MARIANI PETER JChief Financial OfficerOct 30Option Exercise5.0460,000302,40080,683Nov 03 05:11 PM
MARIANI PETER JChief Financial OfficerOct 30Sale12.4175,683939,3535,000Nov 03 05:11 PM
Freitag Gregory GeneDirectorSep 15Option Exercise3.6713,04647,879244,530Sep 17 04:57 PM
Freitag Gregory GeneGeneral CounselMay 29Option Exercise3.50125,000437,500231,484Jun 01 07:08 AM
Donovan Michael PatrickVP OperationsMay 28Option Exercise4.1615,00062,40043,646Jun 01 07:08 AM
DeVinney Erick WayneVP, Clinical&Translational ScApr 28Option Exercise0.272,53068351,056Apr 29 05:56 PM
Zaderej Karen L.CEOApr 16Option Exercise4.8111,62555,916658,869Apr 20 08:17 AM
Rudelius Robert JamesDirectorJan 01Option Exercise2.7513,00035,75047,591Jan 03 08:03 AM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.